These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33791847)

  • 1. Long-term analysis of patients with benign multiple sclerosis: new insights about the disability course.
    Mathey G; Pisché G; Soudant M; Pittion-Vouyovitch S; Guillemin F; Debouverie M; Epstein J
    J Neurol; 2021 Oct; 268(10):3817-3825. PubMed ID: 33791847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal follow-up of "benign" multiple sclerosis at 20 years.
    Sayao AL; Devonshire V; Tremlett H
    Neurology; 2007 Feb; 68(7):496-500. PubMed ID: 17296915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors.
    Hawkins SA; McDonnell GV
    J Neurol Neurosurg Psychiatry; 1999 Aug; 67(2):148-52. PubMed ID: 10406979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with and long-term outcome of benign multiple sclerosis: a nationwide cohort study.
    Crielaard L; Kavaliunas A; Ramanujam R; Olsson T; Hillert J; Stridh P; Kockum I; Manouchehrinia A
    J Neurol Neurosurg Psychiatry; 2019 Jul; 90(7):761-767. PubMed ID: 30824631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of long-term disability in Chinese patients with multiple sclerosis: A prospective cohort study.
    Zhang Y; Xu Y; Xu T; Yin H; Zhu Y; Peng B; Cui L
    Mult Scler Relat Disord; 2020 Nov; 46():102461. PubMed ID: 32862039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural history of benign multiple sclerosis: Clinical and HLA correlates in a Western Australian cohort.
    Fabis-Pedrini MJ; James I; Seewann A; Yau WY; van de Bovenkamp AA; Sanders FRK; Qiu W; Burton J; Mastaglia FL; Carroll WM; Kermode AG
    J Neurol Sci; 2018 May; 388():12-18. PubMed ID: 29627005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and disability progression in multiple sclerosis in Tunisia: do we really have a more aggressive disease course?
    Sidhom Y; Damak M; Riahi A; Hizem Y; Mrissa R; Mhiri C; Gouider R
    J Neurol Sci; 2014 Aug; 343(1-2):110-4. PubMed ID: 24980939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term effect of delayed treatment on disability in patients with paediatric onset multiple sclerosis: A prospective Danish cohort study.
    Kopp TI; Blinkenberg M; Petersen T; Sorensen PS; Magyari M
    Mult Scler Relat Disord; 2020 May; 40():101956. PubMed ID: 32007654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a two-stage disability progression in multiple sclerosis.
    Leray E; Yaouanq J; Le Page E; Coustans M; Laplaud D; Oger J; Edan G
    Brain; 2010 Jul; 133(Pt 7):1900-13. PubMed ID: 20423930
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disability and prognosis in multiple sclerosis: demographic and clinical variables important for the ability to walk and awarding of disability pension.
    Myhr KM; Riise T; Vedeler C; Nortvedt MW; Grønning R; Midgard R; Nyland HI
    Mult Scler; 2001 Feb; 7(1):59-65. PubMed ID: 11321195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
    Gavoille A; Rollot F; Casey R; Debouverie M; Le Page E; Ciron J; De Seze J; Ruet A; Maillart E; Labauge P; Zephir H; Papeix C; Defer G; Lebrun-Frenay C; Moreau T; Laplaud DA; Berger E; Stankoff B; Clavelou P; Thouvenot E; Heinzlef O; Pelletier J; Al Khedr A; Casez O; Bourre B; Cabre P; Wahab A; Magy L; Camdessanche JP; Maurousset A; Moulin S; Ben NH; Boulos DD; Hankiewicz K; Neau JP; Pottier C; Nifle C; Rabilloud M; Subtil F; Vukusic S;
    Neurology; 2023 Mar; 100(12):e1296-e1308. PubMed ID: 36564207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study.
    He A; Merkel B; Brown JWL; Zhovits Ryerson L; Kister I; Malpas CB; Sharmin S; Horakova D; Kubala Havrdova E; Spelman T; Izquierdo G; Eichau S; Trojano M; Lugaresi A; Hupperts R; Sola P; Ferraro D; Lycke J; Grand'Maison F; Prat A; Girard M; Duquette P; Larochelle C; Svenningsson A; Petersen T; Grammond P; Granella F; Van Pesch V; Bergamaschi R; McGuigan C; Coles A; Hillert J; Piehl F; Butzkueven H; Kalincik T;
    Lancet Neurol; 2020 Apr; 19(4):307-316. PubMed ID: 32199096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pediatric Multiple Sclerosis in Rio de Janeiro: Secondary Progression and Disability.
    Cerqueira Pinto SC; Ferreira Vasconcelos CC; Aurenção JCK; Alvarenga MP; das Graças Gomes Camargo SM; Santos Thuler LC; Alvarenga RP
    Pediatr Neurol; 2019 May; 94():48-54. PubMed ID: 30850228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early clinical markers of aggressive multiple sclerosis.
    Malpas CB; Manouchehrinia A; Sharmin S; Roos I; Horakova D; Havrdova EK; Trojano M; Izquierdo G; Eichau S; Bergamaschi R; Sola P; Ferraro D; Lugaresi A; Prat A; Girard M; Duquette P; Grammond P; Grand'Maison F; Ozakbas S; Van Pesch V; Granella F; Hupperts R; Pucci E; Boz C; Sidhom Y; Gouider R; Spitaleri D; Soysal A; Petersen T; Verheul F; Karabudak R; Turkoglu R; Ramo-Tello C; Terzi M; Cristiano E; Slee M; McCombe P; Macdonell R; Fragoso Y; Olascoaga J; Altintas A; Olsson T; Butzkueven H; Hillert J; Kalincik T
    Brain; 2020 May; 143(5):1400-1413. PubMed ID: 32386427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we predict benign multiple sclerosis? Results of a 20-year long-term follow-up study.
    Sartori A; Abdoli M; Freedman MS
    J Neurol; 2017 Jun; 264(6):1068-1075. PubMed ID: 28417192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relapse recovery: The forgotten variable in multiple sclerosis clinical trials.
    Kantarci OH; Zeydan B; Atkinson EJ; Conway BL; Castrillo-Viguera C; Rodriguez M
    Neurol Neuroimmunol Neuroinflamm; 2020 Mar; 7(2):. PubMed ID: 31848231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How long can you keep working with benign multiple sclerosis?
    Glad SB; Nyland H; Aarseth JH; Riise T; Myhr KM
    J Neurol Neurosurg Psychiatry; 2011 Jan; 82(1):78-82. PubMed ID: 20802029
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset MS is associated with an increased rate of reaching disability milestones.
    Andersen MA; Buron MD; Magyari M
    J Neurol; 2021 Sep; 268(9):3352-3360. PubMed ID: 33677675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in disability in patients with multiple sclerosis: a 20-year prospective population-based analysis.
    Hirst C; Ingram G; Swingler R; Compston DA; Pickersgill T; Robertson NP
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1137-43. PubMed ID: 18303106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is benign MS really benign? What a meaningful classification beyond the EDSS must take into consideration.
    Ellenberger D; Flachenecker P; Haas J; Hellwig K; Paul F; Stahmann A; Warnke C; Zettl UK; Rommer PS;
    Mult Scler Relat Disord; 2020 Nov; 46():102485. PubMed ID: 32980646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.